Mankind Pharma [MANKIND] vs Dr. Reddy's [DRREDDY] Detailed Stock Comparison

Mankind Pharma Ltd.

NSE
Loading...

Dr. Reddy's Laboratories Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Mankind Pharma Ltd. wins in 4 metrics, Dr. Reddy's Laboratories Ltd. wins in 16 metrics, with 0 ties. Dr. Reddy's Laboratories Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Mankind Pharma Ltd. Dr. Reddy's Laboratories Ltd. Better
P/E Ratio (TTM) 53.43 19.40 Dr. Reddy's Laboratories Ltd.
Price-to-Book Ratio 6.23 2.94 Dr. Reddy's Laboratories Ltd.
Debt-to-Equity Ratio 53.89 18.03 Dr. Reddy's Laboratories Ltd.
PEG Ratio -1.36 -1.35 Dr. Reddy's Laboratories Ltd.
EV/EBITDA 30.12 12.80 Dr. Reddy's Laboratories Ltd.
Profit Margin (TTM) 12.79% 16.36% Dr. Reddy's Laboratories Ltd.
Operating Margin (TTM) 19.53% 16.42% Mankind Pharma Ltd.
EBITDA Margin (TTM) 19.53% 16.42% Mankind Pharma Ltd.
Return on Equity 13.67% 16.10% Dr. Reddy's Laboratories Ltd.
Return on Assets (TTM) 7.17% 7.96% Dr. Reddy's Laboratories Ltd.
Free Cash Flow (TTM) $18.83B $12.03B Mankind Pharma Ltd.
Dividend Yield 0.04% 11.59% Dr. Reddy's Laboratories Ltd.
1-Year Return -3.73% 4.18% Dr. Reddy's Laboratories Ltd.
Price-to-Sales Ratio (TTM) 6.84 3.17 Dr. Reddy's Laboratories Ltd.
Enterprise Value $973.91B $1,085.11B Dr. Reddy's Laboratories Ltd.
EV/Revenue Ratio 7.00 3.14 Dr. Reddy's Laboratories Ltd.
Gross Profit Margin (TTM) 72.58% 53.63% Mankind Pharma Ltd.
Revenue per Share (TTM) $337 $415 Dr. Reddy's Laboratories Ltd.
Earnings per Share (Diluted) $43.14 $67.88 Dr. Reddy's Laboratories Ltd.
Beta (Stock Volatility) 0.39 0.30 Dr. Reddy's Laboratories Ltd.

Mankind Pharma Ltd. vs Dr. Reddy's Laboratories Ltd. Stock Performance Analysis

Loading Price Chart...

MANKIND
DRREDDY

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Mankind Pharma Ltd.-0.70%-2.10%4.95%7.35%7.43%9.47%
Dr. Reddy's Laboratories Ltd.0.33%-4.22%-1.86%-2.16%-1.36%0.79%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Mankind Pharma Ltd.-3.73%62.02%70.36%70.36%70.36%70.36%
Dr. Reddy's Laboratories Ltd.4.18%41.36%24.02%106.24%313.72%874.29%

Performance & Financial Health Analysis: Mankind Pharma Ltd. vs Dr. Reddy's Laboratories Ltd.

MetricMANKINDDRREDDY
Market Information
Market Cap i₹946.57B₹1.10T
Market Cap CategoryLarge capLarge cap
10 Day Avg. Volume i498,8743,912,162
90 Day Avg. Volume i593,3342,668,229
Last Close₹2,353.00₹1,267.50
52 Week Range₹1,909.70 - ₹2,716.50₹1,148.40 - ₹1,379.70
% from 52W High-13.38%-8.13%
All-Time High₹3,054.80 (Dec 23, 2024)₹1,421.49 (Aug 19, 2024)
% from All-Time High-22.97%-10.83%
Growth Metrics
Quarterly Revenue Growth0.10%0.04%
Quarterly Earnings Growth0.08%-0.14%
Financial Health
Profit Margin (TTM) i0.13%0.16%
Operating Margin (TTM) i0.20%0.16%
Return on Equity (TTM) i0.14%0.16%
Debt to Equity (MRQ) i53.8918.03
Cash & Liquidity
Book Value per Share (MRQ)₹370.26₹447.25
Cash per Share (MRQ)₹84.74₹99.20
Operating Cash Flow (TTM) i₹26.50B₹63.11B
Levered Free Cash Flow (TTM) i₹19.91B₹13.47B
Dividends
Last 12-Month Dividend Yield i0.04%11.59%
Last 12-Month Dividend i₹1.00₹146.30

Valuation & Enterprise Metrics Analysis: Mankind Pharma Ltd. vs Dr. Reddy's Laboratories Ltd.

MetricMANKIND (Apr 24, 2026)DRREDDY (Apr 26, 2026)
Price Ratios
P/E Ratio (TTM) i53.4319.40
Forward P/E i38.6624.12
PEG Ratio i-1.36-1.35
Price to Sales (TTM) i6.843.17
Price to Book (MRQ) i6.232.94
Market Capitalization
Market Capitalization i₹946.57B₹1.10T
Enterprise Value i₹973.91B₹1.09T
Enterprise Value Metrics
Enterprise to Revenue i7.003.14
Enterprise to EBITDA i30.1212.80
Risk & Other Metrics
Beta i0.390.30
Book Value per Share (MRQ) i₹370.26₹447.25

Financial Statements Comparison: Mankind Pharma Ltd. vs Dr. Reddy's Laboratories Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricMANKIND (2025)DRREDDY (2025)
Revenue/Sales i122.07B325.54B
Cost of Goods Sold i35.69B135.11B
COGS % of Revenue i29.2%41.5%
Gross Profit i86.38B190.43B
Gross Margin i70.8%58.5%
Research & Development iN/A27.38B
Operating Income (EBIT) i25.16B72.01B
Operating Margin i20.6%22.1%
EBITDA i32.48B91.97B
EBITDA Margin i26.6%28.3%
Pre-Tax Income i25.16B76.78B
Pre-Tax Income % of Revenue i20.6%23.6%
Income Tax i5.10B19.54B
Income Tax % of Revenue i4.2%6.0%
Net Income (Profit) i20.11B57.25B
Profit Margin i16.5%17.6%

Balance Sheet & Liquidity Metrics

MetricMANKIND (2025)DRREDDY (2025)
Cash & Equivalents i4.07B14.65B
Total Current Assets i69.88B250.11B
Total Current Assets % of Revenue i57.2%76.8%
Total Current Liabilities i56.64B130.39B
Total Current Liabilities % of Revenue i46.4%40.1%
Long-Term Debt i55.40B7.86B
Long-Term Debt % of Revenue i45.4%2.4%
Total Shareholders Equity i145.68B337.17B
Retained Earnings i119.07B315.79B
Retained Earnings % of Revenue i97.5%97.0%
Property, Plant & Equipment i29.08B0

Cash Flow Statement Comparison

MetricMANKIND (2025)DRREDDY (2025)
Operating Cash Flow i26.50B64.09B
Operating Cash Flow % of Revenue i21.7%19.7%
Capital Expenditures i-4.59B-26.99B
Free Cash Flow i18.83B12.03B
FCF Margin i15.4%3.7%
Debt Repayment i-50.73B-1.29B
Common Stock Repurchase iN/A-1.39B

Short Interest & Institutional Ownership Analysis

MetricMANKINDDRREDDY
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i412.83M832.57M
Float Shares i112.84M599.15M
% Held by Insiders i75.27%29.45%
% Held by Institutions i17.86%51.84%
% Held by Public i6.87%18.71%

Dividend Analysis & Yield Comparison: Mankind Pharma Ltd. vs Dr. Reddy's Laboratories Ltd.

MetricMANKINDDRREDDY
Last 12-Month Dividend i₹1.00₹146.30
Last 12-Month Dividend Yield i0.04%11.59%
3-Year Avg Annual Dividend i₹0.33₹49.30
3-Year Avg Dividend Yield i0.04%3.74%
3-Year Total Dividends i₹1.00₹147.90
Ex-Dividend DateAug 08, 2025Jul 10, 2025